Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Change in Accured Expenses: 2022-2024

Historic Change in Accured Expenses for Lexeo Therapeutics (LXEO) over the last 3 years, with Dec 2024 value amounting to $3.4 million.

  • Lexeo Therapeutics' Change in Accured Expenses fell 133.48% to -$2.1 million in Q4 2023 from the same period last year, while for Dec 2023 it was $2.1 million, marking a year-over-year change of. This contributed to the annual value of $3.4 million for FY2024, which is 61.02% up from last year.
  • According to the latest figures from FY2024, Lexeo Therapeutics' Change in Accured Expenses is $3.4 million, which was up 61.02% from $2.1 million recorded in FY2023.
  • In the past 5 years, Lexeo Therapeutics' Change in Accured Expenses ranged from a high of $4.5 million in FY2022 and a low of $2.1 million during FY2023.
  • Over the past 3 years, Lexeo Therapeutics' median Change in Accured Expenses value was $3.4 million (recorded in 2024), while the average stood at $3.3 million.
  • Per our database at Business Quant, Lexeo Therapeutics' Change in Accured Expenses tumbled by 53.28% in 2023 and then skyrocketed by 61.02% in 2024.
  • Lexeo Therapeutics' Change in Accured Expenses (Yearly) stood at $4.5 million in 2022, then crashed by 53.28% to $2.1 million in 2023, then soared by 61.02% to $3.4 million in 2024.